Expanding Access to Care Through Telemedical Support for Vital Sign Monitoring in High-risk Patients With Cancer
NCT: NCT06364748 · TERMINATED
Brief Summary
A randomized trial of remote blood pressure monitoring, compared to usual care, in patients receiving bevacizumab to determine whether remote blood pressure monitoring improves the collection of blood pressure data, identification and management of clinically significant hypertension, and patient satisfaction.
Frequently Asked Questions
What is Expanding Access to Care Through Telemedical Support for Vital Sign Monitoring in High-risk Patients With Cancer?
Expanding Access to Care Through Telemedical Support for Vital Sign Monitoring in High-risk Patients With Cancer is a clinical trial registered under NCT06364748. Current status: TERMINATED.
What is the status of NCT06364748?
The current status of NCT06364748 (Expanding Access to Care Through Telemedical Support for Vital Sign Monitoring in High-risk Patients With Cancer) is: TERMINATED.
When did Expanding Access to Care Through Telemedical Support for Vital Sign Monitoring in High-risk Patients With Cancer start?
Expanding Access to Care Through Telemedical Support for Vital Sign Monitoring in High-risk Patients With Cancer started on 2024-03-11.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.